Abstract
1482O - Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have